Cognitive training for children and adolescents with fragile X syndrome: A randomized controlled trial of Cogmed

David Hessl, Julie B. Schweitzer, Danh V Nguyen, Yingratana A. McLennan, Cindy Johnston, Ryan Shickman, Yanjun Chen

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Background: Individuals with fragile X syndrome (FXS) typically demonstrate profound executive function (EF) deficits that interfere with learning, socialization, and emotion regulation. We completed the first large, non-pharmacological controlled trial for FXS, designed to evaluate the efficacy of Cogmed, a computer/tablet-based working memory (WM) training program. Methods: The study was a randomized, blinded, parallel two-arm controlled trial in 100 children and adolescents with FXS (63 male, 37 female; 15.28 ± 3.36 yrs.). Participants were randomized equally to adaptive (difficulty level adjusted to performance) or non-adaptive (control) Cogmed training. Participants were assessed at home using objective measures of WM (primary outcome) and EF at baseline, following 20-25 caregiver-supported sessions over 5-6 weeks, and at follow-up 3 months after cessation of training. Parents and teachers provided ratings of WM, attention, and EF. Results: The WM composite and selective domains of EF (distractibility, cognitive flexibility), as well as parent- and teacher-reported attention and EF, significantly improved across the full study sample, with many changes maintained at follow-up. However, comparisons of improvement between adaptive and non-adaptive control conditions did not differ, showing that progressively challenging the WM system by expanding span length did not provide added benefit overall. Conclusions: Further experimental comparisons are needed before Cogmed working memory training can be considered empirically validated for children with FXS, forming the basis of treatment recommendation. However, given that prior studies show no significant changes on these measures in FXS without treatment, that improvements were maintained for 3 months, and that blinded teachers reported improvements in the classroom, the modest benefits seen in both adaptive and non-adaptive groups overall are unlikely to be attributable to placebo or practice effects alone. Future analyses examining inter-individual differences (e.g., baseline capacity, training efficiency, co-morbidity, training environment, characteristics of training aide) may help to link this intervention to outcomes and potential transfer effects. Trial registration: US National Institutes of Health (ClinicalTrials.gov), NCT02747394.

Original languageEnglish (US)
Article number4
JournalJournal of Neurodevelopmental Disorders
Volume11
Issue number1
DOIs
StatePublished - Apr 15 2019

Keywords

  • FMR1 gene
  • Fragile X mental retardation protein
  • Intellectual disability
  • Treatment
  • Working memory

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Pathology and Forensic Medicine
  • Clinical Neurology
  • Cognitive Neuroscience

Fingerprint Dive into the research topics of 'Cognitive training for children and adolescents with fragile X syndrome: A randomized controlled trial of Cogmed'. Together they form a unique fingerprint.

  • Cite this